ϩ channel (ENaC) mutations are associated with several human disorders, underscoring the importance of these channels in human health. Recent human genome sequencing projects have revealed a large number of ENaC gene variations, several of which have been found in individuals with salt-sensitive hypertension, cystic fibrosis, and other disorders. However, the functional consequences of most variants are unknown. In this study, we used the Xenopus oocyte expression system to examine the functional properties of a human ENaC variant. Oocytes expressing ␣␤␥L511Q human ENaCs showed 4.6-fold greater amiloridesensitive currents than cells expressing wild-type channels. The ␥L511Q variant did not significantly alter channel surface expression. Single channel recordings revealed that the variant had fourfold higher open probability than wild type. In addition, ␥L511Q largely eliminated the Na ϩ self-inhibition response, which reflects a downregulation of ENaC open probability by extracellular Na ϩ . Moreover, ␥L511Q diminished chymotrypsin-induced activation of the mutant channel. We conclude that ␥L511Q is a gain-of-function human ENaC variant. Our results suggest that ␥L511Q enhances ENaC activity by increasing channel open probability and dampens channel regulation by extracellular Na ϩ and proteases.
EPITHELIAL NA
ϩ CHANNELS (ENaCs) selectively allow extracellular Na ϩ to enter epithelial cells and play essential roles in the regulation of blood pressure and airway surface liquid volume. Mutations in ENaC subunits cause Mendelian diseases such as Liddle syndrome and pseudohypoaldosteronism type I and are linked to bronchiectasis with or without elevated sweat chloride (34, 41) . Genetic studies have shown that selected common polymorphisms in ENaC genes are associated with increases in blood pressure or changes in the salt sensitivity of blood pressure (4, 5, 7, 19, 22, 23, 46) .
Human genome sequencing efforts have identified an unexpectedly large number of genetic variations, including single nucleotide polymorphisms (SNPs), small insertions and deletions (INDELs), and structural or copy number variations (CNVs; Ref. 15) . The availability of large sequencing databases has fueled genome wide association studies that have led to discoveries of genes and pathways involved in several common diseases or complex traits (44) . However, one of the major challenges in understanding the genetic basis of human diseases lies in the translation of gene variations into molecular mechanisms that are relevant to particular diseases (31) . This information should accelerate the development and implementation of variation-targeted therapies for specific disorders.
Functional ENaC complexes typically contain three homologous subunits termed ␣, ␤, and ␥, encoded by the genes SCNN1A, SCNN1B, and SCNN1G, respectively. All three subunits contribute to the Na ϩ selective pore, the central component of these channels (24, 25, 39) . A survey of the single nucleotide polymorphism database dbSNP (build 137, released June 2012 by the National Center for Biotechnology Information) revealed 849, 2,039, and 879 variations in human SCNN1A, SCNN1B, and SCNN1G, respectively. These include SNPs, INDELs, and microsatellite repeats. Aside from a small number of variants (2, 16, 20, 33, 36, 43) , the functional properties of the vast majority of these ENaC variants are unknown.
Recent studies aided by the resolved structure of an acid sensing ion channel 1 (ASIC1; a member of ENaC/Degenerin family) suggest that two short loops located in the palm domain, connecting the ␤ 1 -␤ 2 -strands and the ␤ 11 -␤ 12 -strands, have important roles in ASIC1 desensitization (27, 28, 42) . A large conformational change of these two loops was revealed by comparing resolved desensitized ASIC1 structures and conductive, psalmotoxin bound ASIC1 structures (3). We recently identified two residues within the loops connecting the ␤ 1 -␤ 2 -and ␤ 11 -␤ 12 -strands of mouse ␥ENaC (␥H88 and ␥D516) as determinants of a low affinity inhibitory Zn 2ϩ binding site (13) . In this study, we identified a nonsynonymous variant (␥L511Q, reference sequence ID: rs113234492) that is located within the ␤ 11 -␤ 12 -loop of the human ␥ENaC subunit. We show that ␥L511Q is a functional human ENaC (hENaC) variant that enhances channel open probability (P o ).
MATERIALS AND METHODS
Materials. All reagents were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted.
Site-directed mutagenesis. Point mutations were generated in ␥hENaC cDNA using the QuikChange II XL site-directed mutagenesis kit (Stratagene). Mutations were confirmed by direct sequencing. Wild-type (WT) and mutant cRNAs were synthesized using T7 or SP6 RNA polymerase (Ambion). All synthesized cRNAs were purified using an RNA purification kit (Qiagen), and their concentrations were quantified by spectrophotometry.
ENaC expression and two-electrode voltage clamp. ENaC expression in Xenopus oocytes and two-electrode voltage clamp were performed as previously reported (40) . Stage V and VI oocytes free of follicle cell layers were injected with 3 ng of cRNA for each hENaC subunit per oocyte and incubated 20 -48 h at 18°C in modified Barth's saline [MBS; 88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO 3, 15 mM HEPES, 0.3 mM Ca (NO 3)2, 0.41 mM CaCl2, 0.82 mM MgSO4, 10 g/ml sodium penicillin, 10 g/ml streptomycin sulfate, and 100 g/ml gentamycin sulfate, pH 7.4]. The University of Pittsburgh Institutional Animal Care and Use Committee approved the animal protocol.
All experiments were carried out at room temperature (20 -24°C) 1 day after injection. Two-electrode voltage clamp was performed using an Axoclamp 900A amplifier and a DigiData 1440A interface con-trolled by pClamp 10 (Molecular Devices, Sunnyvale, CA). Oocytes were placed in a recording chamber from Warner Instruments (Hamden, CT) and perfused with bath solutions at a constant flow rate of 12-15 ml/min. Oocytes were continuously clamped at Ϫ100 mV or at a series of voltages to generate current-voltage (I-V) curves.
Surface expression. The surface expression of ENaCs in oocytes was examined using a mouse ␤-subunit with an extracellular FLAG epitope tag, as previously reported (11) . Briefly, oocytes were injected with 3 ng/subunit WT human ␣-subunit cRNA, WT, or mutant human ␥-subunit cRNA and mouse ␤-subunit cRNA with an extracellular FLAG epitope tag (DYKDDDDK) that was inserted between residues T137 and R138. Parallel control studies were performed with oocytes injected with WT human ␣-and ␥-subunit cRNAs and WT (non-FLAG tagged) mouse ␤-subunit cRNA. Two days after cRNA injection, the surface expression assay was performed on ice, except for the last step that was at room temperature (20 -24°C) . Following a 30-min incubation in MBS (without antibiotics) supplemented with 1% bovine serum albumin (MBS/BSA), oocytes were incubated for 1 h with MBS/BSA supplemented with 1 g/ml of a mouse monoclonal anti-FLAG antibody (M2; Sigma). Oocytes were then washed for 1 h in MBS/BSA and incubated with MBS/BSA supplemented with 1 g/ml of a horseradish peroxidase coupled secondary antibody [peroxidase-conjugated AffiniPure F(ab=)2 fragment goat anti-mouse IgG; Jackson ImmunoResearch, West Grove, PA] for 1 h. Cells were extensively washed and transferred to MBS without BSA. Individual oocytes were placed in 1.5-ml microtubes with 100 l of SuperSignal ELISA femto maximum sensitivity substrates (Thermo Scientific, Rockford, IL) and incubated at room temperature for 1 min, and chemiluminescence in relative light units were quantified in a TD-20/20 Luminometer (Promega, Madison, WI).
Patch clamp. Cell-attached patch clamp was performed with oocytes expressing WT or mutant hENaCs. Both pipette and bath solutions contained 110 mM NaCl, 2 mM KCl, 2 mM CaCl 2, and 10 mM HEPES, pH 7.4. Patch clamp was carried out using a PC-One patch-clamp amplifier (Dagan, Minneapolis, MN) and a DigiData 1322A interface connected to a PC. Cell-attached patches were clamped at Ϫ100 mV (negative value of pipette potential). pClamp 8 or 10 software (Molecular Devices, Sunnyvale, CA) was used for data acquisition and analyses. Single-channel recordings were acquired at 5 kHz, filtered at 1 kHz with a built-in Bessel filter. Channel Po was estimated with the single-channel search function of pClamp 10 from recordings that were a minimum of 5 min in length. Unitary currents were determined by cursor measurements. Na ϩ self-inhibition. Na ϩ self-inhibition responses were examined as previously reported (14, 37) . Briefly, Na ϩ self-inhibition responses were determined by measuring the decrease in current from the peak (Ipeak) to the steady state (Iss) elicited by a rapid increase in extracellular Na ϩ concentration from 1 to 110 mM at a holding potential of Ϫ100 mV. The [Na ϩ ] jump was performed by rapidly replacing a 1 mM Na ϩ bath solution (NaCl-1 containing 1 mM NaCl, 109 mM N-methyl-D-glucamine, 2 mM KCl, 2 mM CaCl2, and 10 mM HEPES, pH 7.4) with a 110 mM Na ϩ bath solution (NaCl-110 containing 110 mM NaCl, 2 mM KCl, 2 mM CaCl2, and 10 mM HEPES, pH 7.4). Amiloride (10 M) was subsequently added to determine the amiloride-insensitive component of the whole cell current. Solution exchange was performed with a 16-channel teflon valve perfusion system from AutoMate Scientific (Berkeley, CA). The magnitude of Na ϩ self-inhibition was represented by the ratio of amiloride-sensitive Iss to Ipeak. The time constants for Na ϩ self-inhibition were estimated by fitting the first 40-s current decay from Ipeak with a standard exponential function in the pClamp software.
Examination of the effect of chymotrypsin. The effect of chymotrypsin on whole cell hENaC currents was examined by comparing currents measured in the absence and presence of 2 g/ml ␣-chymotrypsin applied in NaCl-110 bath solution.
Statistical analyses. Data are presented as means Ϯ SE. Student's t-test or ANOVA followed by Tukey's post hoc test were used for comparisons with MS Excel or Origin Pro 8.5 software (OriginLab, Northampton, MA). Significance levels are specified in the text or figure legends.
RESULTS

␥L511Q increases whole cell currents of hENaCs expressed in Xenopus oocytes.
To investigate the functional properties of the ␥L511Q variant, we generated the L511Q mutation in ␥hENaC cDNA and expressed the mutant ␥-subunit together with WT ␣-and ␤-subunits in Xenopus oocytes. Amiloridesensitive currents measured in oocytes expressing either the mutant (␣␤␥L511Q) or WT (␣␤␥) hENaCs were compared. Oocytes expressing the ␥L511Q variant had 4.6-fold greater amiloride-sensitive currents than WT (P Ͻ 0.001; Fig. 1 ). Linear current-voltage (I-V) relationships were observed in oocytes expressing either WT or mutant channels.
␥L511Q does not alter levels of hENaC surface expression. The increased whole cell currents in oocytes expressing the ␥L511Q mutant could reflect increases in the number of channels in the plasma membrane, unitary current, or P o . We determined surface expression levels of both WT and the mutant in oocytes with a chemiluminescence assay, using a mouse ␤-subunit with an external epitope tag. As shown in Fig. 2 , similar levels of surface expression were observed in oocytes expressing the WT and mutant channels. These results indicate that the increased whole cell current of ␥L511Q channels, compared with WT, was not due to an increase in the number of channels at the plasma membrane.
␥L511Q increases ENaC P o . We performed cell-attached patch-clamp studies in oocytes to determine single channel properties of both WT and ␣␤␥L511Q channels. The unitary currents of ␣␤␥L511Q channels at Ϫ100 mV were 0.48 Ϯ 0.02 pA (n ϭ 8), indistinguishable from WT (0.48 Ϯ 0.02 pA; n ϭ 10; P Ͼ 0.05; Fig. 3 ). However, the P o of the mutant (0.44 Ϯ 0.03; n ϭ 8) was fourfold greater than WT (0.11 Ϯ 0.04; n ϭ 10; P Ͻ 0.001). These results demonstrate that the increased whole cell current in oocytes expressing the ␥L511Q mutant channels reflect an increased P o .
␥L511Q diminishes the Na ϩ self-inhibition response. Our observation that ␥L511Q exhibited a dramatically increased P o , compared with WT, raised the possibility that this variant might alter the response of ENaC to defined extrinsic regulators of channel gating. We examined whether this variant affected Na ϩ self-inhibition, a downregulation of ENaC P o by extracellular Na ϩ (24, 39). Oocytes expressing WT channels showed a typical Na ϩ self-inhibition response, represented as a current decay following a rapid increase in inward Na ϩ current associated with an acute increase in the bath Na ϩ concentration. In contrast, oocytes expressing the ␣␤␥L511Q variant displayed a markedly blunted Na ϩ self-inhibition response (Fig. 4) . We determined the ratio of the steady state to peak current following an acute increase in bath Na ϩ concentration (I ss /I peak ), which is a measure of the magnitude of the Na ϩ self-inhibition response. The I ss /I peak of the variant was 0.83 Ϯ 0.01 (n ϭ 6), significantly greater than the WT value of 0.58 Ϯ 0.04 (n ϭ 6; P Ͻ 0.001). The Na ϩ self-inhibition response of the variant was also significantly slower than WT with the estimated time constants of 10.1 Ϯ 0.8 s (n ϭ 6) for the variant and 3.7 Ϯ 0.4 s (n ϭ 6) for WT (P Ͻ 0.001). ENaC P o is controlled in part by Na ϩ self-inhibition in the presence of physiological concentrations of Na ϩ (24, 39). The suppressed Na ϩ self-inhibition response by ␥L511Q may contribute to the observed higher P o of the variant. However, there are likely other factors that contribute to the differences in whole cell current and P o values of the WT and variant (Figs. 1 and 3) .
␥L511Q blunts chymotrypsin activation of ENaC. Certain proteases activate ENaC by site-specific cleavage of extracellular regions of the ␣ and ␥-subunits, releasing imbedded inhibitory tracts (26, 35) . The magnitude of effect of the external proteases on ENaC activity reflects, in part, the P o of existing channels and the relative abundance of the cleaved and noncleaved channels in cell membranes. We reasoned that ␥L511Q might reduce the activating effect of extrinsic proteases, based on the larger P o of the variant channel. Indeed, addition of 2 g/ml ␣-chymotrypsin to the bath solution increased the Na ϩ current of WT by 4.3-fold but increased the current of the mutant only 1.3-fold (P Ͻ 0.001 vs. WT; Fig. 5 ). These results indicate that ␥L511Q blunts the effect of chymotrypsin on channel activation.
Effects of other substituents at ␥L511. We further investigated the functional role of ␥L511 by introducing residues with different properties at this site. All substitutions of ␥L511 significantly increased amiloride-sensitive whole cell Na ϩ currents and reduced the Na ϩ self-inhibition response, although to varying degrees (Fig. 6) . Interestingly, the most conservative substitution (␥L511I) results in a significantly blunted increase in whole cell Na ϩ currents, when compared with ␥L511A, ␥L511R, and ␥L511Q, (P Ͻ 0.05, ANOVA), and more robust Na ϩ self-inhibition when compared with substitutions of Arg, Ala, or Glu at this site (P Ͻ 0.05 for both I ss /I peak and tau, ANOVA).
DISCUSSION
A growing number of hENaC nonsynonymous variants have been identified. Based on the location of the ␥L511Q variant within the ␤ 11 -␤ 12 -loop of the palm domain, we predicted that this variant would affect channel activity and P o . We found that the ␥L511Q variant was associated with a remarkable increase in ENaC activity that largely reflected an increase in channel P o . The variant did not alter levels of channel surface expression, with the caveat that our surface expression studies used a mouse ␤-subunit with an external FLAG tag. We are not aware of studies suggesting that substituting a mouse ␤-subunit for a human ␤-subunit will alter channel trafficking. The increased P o was associated with a blunted inhibitory response of the channel to external Na ϩ (i.e., Na ϩ self-inhibition) as well as a blunted activating response to the protease chymotrypsin.
Interestingly, the P o of the ␥L511Q variant (0.44 Ϯ 0.03; n ϭ 8) is not as high as other mutants that we have studied, such as ␤S518K, ␥H239F, ␥G542C, ␥R143A-⌬144 -186, and ␥M438V in mouse ENaC (6, 10, 12, 29, 45) . These results suggest that the ␥L511Q variant does not alter ENaC gating transitions to the same extent as other mutants.
The average P o of 0.11 we observed for WT hENaC in oocytes is similar to previously reported P o values (32, 33) . Normalized Currents * Fig. 6 . Substitutions of ␥L511 result in increased channel activity and reduced Na ϩ self-inhibition response. A: normalized whole cell amiloride-sensitive Na ϩ currents of WT (Leu) and ␥L511 mutants. Normalized currents (at Ϫ100 mV) were obtained as described in Fig. 1 legend. Data were from three batches of oocytes (n ϭ 35-43). Whole cell current measurements with the ␥L511Q were performed in parallel with the other mutants. *P Ͻ 0.05 between the Ile mutant and other mutants. B: magnitudes and time constants of the Na Within the pool of channels at the plasma membrane are those with a very low P o that have been termed "near-silent" channels (9, 33) . These low activity channels can be activated by externally applied proteases such as neutrophil elastase, trypsin, and chymotrypsin (8, 9, 17, 33) . Selected proteases also increase the activity of channels with a moderate P o (26, 33) . The markedly diminished response of ␣␤␥L511Q channels to chymotrypsin suggests that this variant increases the activity of both "near-silent" and moderately active channels, similar to what is observed when ENaCs are treated with extracellular proteases such as trypsin or chymotrypsin. Proteases activate ENaC at least in part by interfering with Na ϩ self-inhibition (14, 26, 38) , and it is notable that ␣␤␥L511Q channels also have a suppressed Na ϩ self-inhibition response. Residue ␥L511 is homologous to L414 of cASIC1, located within a region linking the ␤ 11 -and ␤ 12 -strands of palm domain (Fig. 7) . This Leu residue is highly conserved among ENaCs, ASICs and other members of ENaC/Degenerin family. A Leu resides at this site in all family members except for the ␤-subunit of ENaC, which has a Phe residue at this site (Fig.  7C ). Residues within this linker region as well as the ␤ 1 -␤ 2 -linker region have been implicated in the regulation of ASIC and ENaC gating, including two residues (mouse ␥H88 and ␥D516) that have a role in the regulation of ENaC gating by Zn 2ϩ (13, 27, 42) . Comparisons of resolved psalmotoxinbound ASIC1a structures with a desensitized ASIC1a structure (18) revealed large structural rearrangements of the residues linking the ␤ 11 -␤ 12 -and ␤ 1 -␤ 2 -strands in the palm domain (3). In a low pH structure the L414 side chain forms multiple hydrophobic contacts with residues of an adjacent subunit (Fig.  7B) . However, in a high pH structure, the L414 side chain interacts with a hydrophobic residue of the ␤ 1 -␤ 2 -linker of the same subunit (3). We speculate that ␥L511Q introduces a hydrophilic side chain within a hydrophobic pocket at the subunit interface, disrupting the native hydrophobic contacts, which facilitates a separation of the palm domain of ␥-subunit and the thumb domain of an adjacent subunit, stabilizing the open state of the pore. Consistent with this idea, additional substitutions of ␥L511 with hydrophilic residues (␥L511E and ␥L511R) significantly increased ENaC currents and suppressed Na ϩ self-inhibition responses. A conservative hydrophobic substitution (␥L511I) reduced the magnitude of the increase in Na ϩ current, compared with ␥L511A, ␥L511R, and ␥L511Q, and enhanced the magnitude and rate of Na ϩ self-inhibition, compared with ␥L511A, ␥L511E, and ␥L511R. In contrast, channels with a ␥L511A substitution behaved in a manner similar to ␥L511E and ␥L511R, suggesting that the length of the hydrophobic side chain at this site influences its interactions with nearby residues (Fig. 7B) .
The frequency and clinical relevance of the ␥L511Q variant are not known. Further sequencing efforts are needed to define the frequency of this variant among different populations. It has been suggested that variants of low allele frequency, particularly variants with large effects on physiological processes, may contribute to common diseases (30) . We speculate that individuals with one copy of this gain-of-function variant may have an increased risk of developing salt-sensitive hypertension. In addition, the ␥L511Q variant might modify disease Side chain of L414 of cASIC1a that is homologous to ␥L511 of hENaC is shown as spheres in magenta (arrow). B: an enlarged area showing the contacts of L414 of cASIC1. Side chain of L414 of the subunit C of chicken ASIC1a (green subunit) is shown as green sticks (arrow). Side chains of residues within 5 Å to L414 are displayed as spheres in colors (cyan for carbon, red for oxygen, orange for sulfur, and blue for nitrogen). Four ␤-strands (␤1, ␤2, ␤11, and ␤12) in the palm domain are labeled. Structural models were drawn using PyMol 1.3 (1) . C: sequence alignments of selected ENaC/Degenerin members. Alignments were performed with Vector NTI V11 (Invitrogen). Conserved residues are highlighted in yellow. L414 of chicken ASIC1a, corresponding to ␥L511 of hENaC, and residues at this site in other family members are boxed. Secondary structures of the aligned region are shown below the alignment, based on the resolved ASIC1a structures (18, 21) . The ␤11-and ␤12-loop in the high pH structure appears as a continuous ␤-strand from ␤11 to ␤12 (3). Human, mouse, and rat are indicated as h, m, and r, respectively. severity in individuals with one or two mutant CFTR alleles as suggested by others (2, 20, 33) .
In summary, we identified ␥L511Q as a gain-of-function hENaC variant. ␥L511Q shares certain features with ␣W493R when expressed in Xenopus oocytes (33) , including an increase in whole cell current and P o , and suppression of Na ϩ selfinhibition and protease activation. In addition to ␥L511Q, substitutions of ␥L511 with Glu, Arg, Ala, and Ile result in increased channel activity, underscoring the important role of this residue within the palm domain in ENaC gating. Future studies are needed to assess the contribution of this variant in human disease.
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